pipeline Archives -

Genmab axes development of AXL-targeting cancer drug enapotamab vedotin

https://pharmaphorum.com/news/genmab-axes-development-axl-targeting-cancer-drug-enapotamab-vedotin/

Novartis set to overcome $14 billion patent cliff say analysts

https://pharmaphorum.com/news/novartis-set-to-overcome-14-billion-patent-cliff-analyst/

AstraZeneca ‘probably couldn’t run Gilead any better:’ analyst

https://pharmaphorum.com/news/astrazeneca-probably-couldnt-run-gilead-any-better-analyst/

AZ reportedly mulls biggest-ever pharma merger with Gilead

https://pharmaphorum.com/news/az-reportedly-mulls-biggest-ever-pharma-merger-with-gilead/

NodThera raises $55m in Series B round to trial inflammatory disease drugs

https://pharmaphorum.com/news/nodthera-raises/

Failed trial puts future of UCB’s epilepsy drug padsevonil in doubt

https://pharmaphorum.com/news/failed-trial-puts-future-of-ucbs-epilepsy-drug-padsevonil-in-doubt/

Novartis says mid-stage pipeline is setting up strong growth spurt

https://pharmaphorum.com/news/novartis-says-mid-stage-pipeline-is-setting-up-strong-growth-spurt/

Boehringer pins hopes on novel psoriasis drug

https://pharmaphorum.com/news/boehringer-pins-hopes-on-novel-psoriasis-drug/

Infographic: Solving the challenges of immuno-oncology trials

https://pharmaphorum.com/views-and-analysis/overcoming-challenges-immuno-oncology-trials-60-seconds/

Search